Skip to main content
Journal cover image

Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.

Publication ,  Journal Article
Tonorezos, ES; Hudson, MM; Edgar, AB; Kremer, LC; Sklar, CA; Wallace, WHB; Oeffinger, KC
Published in: Lancet Diabetes Endocrinol
July 2015

5 year survival for childhood and adolescent cancer in developed countries is now in excess of 80% and the number of survivors of cancer continues to increase worldwide. After completion of therapy, many of these survivors will face a lifelong risk of endocrine late effects. We summarise the available evidence related to the prevalence and risk factors for endocrine late effects among adult survivors of childhood and adolescent cancer. Present screening, surveillance, and treatment recommendations differ by country and region, so we also highlight the continued effort to harmonise the international guidelines for this population.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet Diabetes Endocrinol

DOI

EISSN

2213-8595

Publication Date

July 2015

Volume

3

Issue

7

Start / End Page

545 / 555

Location

England

Related Subject Headings

  • Young Adult
  • Survivors
  • Risk Factors
  • Radiotherapy
  • Neoplasms
  • Humans
  • Endocrine System Diseases
  • Disease Management
  • Antineoplastic Agents
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tonorezos, E. S., Hudson, M. M., Edgar, A. B., Kremer, L. C., Sklar, C. A., Wallace, W. H. B., & Oeffinger, K. C. (2015). Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer. Lancet Diabetes Endocrinol, 3(7), 545–555. https://doi.org/10.1016/S2213-8587(15)00038-8
Tonorezos, Emily S., Melissa M. Hudson, Angela B. Edgar, Leontien C. Kremer, Charles A. Sklar, W Hamish B. Wallace, and Kevin C. Oeffinger. “Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.Lancet Diabetes Endocrinol 3, no. 7 (July 2015): 545–55. https://doi.org/10.1016/S2213-8587(15)00038-8.
Tonorezos ES, Hudson MM, Edgar AB, Kremer LC, Sklar CA, Wallace WHB, et al. Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer. Lancet Diabetes Endocrinol. 2015 Jul;3(7):545–55.
Tonorezos, Emily S., et al. “Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.Lancet Diabetes Endocrinol, vol. 3, no. 7, July 2015, pp. 545–55. Pubmed, doi:10.1016/S2213-8587(15)00038-8.
Tonorezos ES, Hudson MM, Edgar AB, Kremer LC, Sklar CA, Wallace WHB, Oeffinger KC. Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer. Lancet Diabetes Endocrinol. 2015 Jul;3(7):545–555.
Journal cover image

Published In

Lancet Diabetes Endocrinol

DOI

EISSN

2213-8595

Publication Date

July 2015

Volume

3

Issue

7

Start / End Page

545 / 555

Location

England

Related Subject Headings

  • Young Adult
  • Survivors
  • Risk Factors
  • Radiotherapy
  • Neoplasms
  • Humans
  • Endocrine System Diseases
  • Disease Management
  • Antineoplastic Agents
  • Adult